4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-053003
Director sold 45,539 shares at an average $16.45 ($749,002)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SCHIFF ANDREW N Director | 2022-10-04 | Sale | −7,700 | $16.01 | $123,259 | 626,755 | I |
| SCHIFF ANDREW N Director | 2022-10-06 | Sale | −37,839 | $16.54 | $625,744 | 588,916 | I |
| Open-market sales · 45,539 sh · avg $16.45 · $749,002 | |||||||
Loading xslF345X03/doc4.xml…